Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/30082
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDella Morte, S-
dc.contributor.authorBerti, E-
dc.contributor.authorLalli, C-
dc.contributor.authorModugno, N-
dc.contributor.authorMorgante, F-
dc.contributor.authorSchrag, A-
dc.contributor.authorMakovac, E-
dc.contributor.authorRicciardi, L-
dc.date.accessioned2024-11-10T11:22:09Z-
dc.date.available2024-11-10T11:22:09Z-
dc.date.issued2024-03-23-
dc.identifierORCiD: Francesca Morgante https://orcid.org/0000-0002-9834-3639-
dc.identifierORCiD: Anette Schrag https://orcid.org/0000-0002-9872-6680-
dc.identifierORCiD: Elena Makovac https://orcid.org/0000-0003-0280-0485-
dc.identifierORCiD: Lucia Ricciardi https://orcid.org/0000-0001-9401-3301-
dc.identifier.citationDella Morte, S. et al. (2024) 'Compassionate mind training for people with Parkinson's disease: A pilot study and predictors of response', European Journal of Neurology, 31 (7), pp. 1 - 9. doi: 10.1111/ene.16286.en_US
dc.identifier.issn1351-5101-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/30082-
dc.descriptionData Availability Statement: The data that support the findings of this study are available from the corresponding author upon reasonable request.en_US
dc.descriptionSupporting Information is available online at: https://onlinelibrary.wiley.com/doi/10.1111/ene.16286#support-information-section .-
dc.descriptionElena Makovac and Lucia Ricciardi share senior authorship.-
dc.description.abstractIntroduction: People with Parkinson's disease (PD) often present with disabling neuropsychiatric symptoms. Compassionate mind training (CMT) is a psychological approach effective in reducing stress and promoting psychological well-being. Heart rate variability (HRV), a measure reflecting sympathovagal balance, has been associated with psychological well-being and a compassionate attitude. Aim: To assess the feasibility and effectiveness of CMT in enhancing the quality of life and psychological well-being in PD patients. Additionally, we evaluated HRV as a physiomarker for assessing the CMT outcomes. Methods: Twenty-four PD patients participated in the study. A 6-week online CMT intervention was delivered on a weekly basis. At baseline and post-intervention patients completed questionnaires assessing depression, anxiety and quality of life. In a subsample of 11 patients, HRV was measured at baseline and post-intervention in three conditions: at rest, during stress and after 3 min of deep breathing. Results: The attendance rate was 94.3%. Quality of life and perceived stigma improved post-intervention as compared with baseline (p = 0.02 and p = 0.03 for PD Questionnaire-39 total score and Stigma subscore, respectively). After CMT, patients presented better physiological regulation to stress, as measured by higher HRV as compared with baseline (p = 0.005). Notably, patients who were more resilient to stress at baseline (less decrease in HRV during stress) experienced a more substantial reduction in anxiety and depression following CMT. Conclusions: CMT is feasible and can improve quality of life and stigma in PD patients. HRV emerges as a promising physiomarker for predicting and measuring the outcomes of psychological interventions in PD.en_US
dc.description.sponsorshipNo funding was received for this research.-
dc.format.extent1 - 9-
dc.format.mediumPrint-Electronic-
dc.languageEnglish-
dc.language.isoenen_US
dc.publisherWiley on behalf of European Academy of Neurologyen_US
dc.rightsAttribution-NonCommercial-NoDerivs 4.0 International-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subjectcompassionen_US
dc.subjectheart rate variabilityen_US
dc.subjectneuropsychiatric symptomsen_US
dc.subjectParkinson's diseaseen_US
dc.subjectstigmaen_US
dc.titleCompassionate mind training for people with Parkinson's disease: A pilot study and predictors of responseen_US
dc.typeArticleen_US
dc.date.dateAccepted2024-03-06-
dc.identifier.doihttps://doi.org/10.1111/ene.16286-
dc.relation.isPartOfEuropean Journal of Neurology-
pubs.issue7-
pubs.publication-statusPublished-
pubs.volume31-
dc.identifier.eissn1468-1331-
dc.rights.licensehttps://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.en-
dc.rights.holderThe Authors-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2024 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.2.33 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons